Correction: Park et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013
Reference
- Park, E.; Lee, C.; Kim, N.K.D.; Ahn, Y.H.; Park, Y.S.; Lee, J.H.; Kim, S.H.; Cho, M.H.; Cho, H.; Yoo, K.H.; et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013. [Google Scholar] [CrossRef] [PubMed]
Gene | Mode of Inheritance | No. of Patients (%) | % of Total Patients (n = 291) |
---|---|---|---|
SRNS/FSGS gene | |||
WT1 | AD | 30 (23.6%) | 10.3% |
COQ6 | AR | 11 (8.7%) | 3.8% |
NPHS1 | AR | 11 (8.7%) | 3.8% |
NUP107 | AR | 9 (7.1%) | 3.1% |
COQ8B | AR | 8 (6.3%) | 2.7% |
MYH9 | AD | 6 (4.7%) | 2.1% |
INF2 | AD | 6 (4.7%) | 2.1% |
PAX2 | AD | 5 (3.9%) | 1.7% |
NPHS2 | AR | 4 (3.1%) | 1.4% |
MAFB | AD | 4 (3.1%) | 1.4% |
LAMB2 | AR | 3 (2.4%) | 1.0% |
SMARCAL1 | AR | 3 (2.4%) | 1.0% |
MT-TL1 | Mitochondrial | 3 (2.4%) | 1.0% |
ACTN4 | AD | 1 (0.8%) | 0.3% |
LMX1B | AD | 1 (0.8%) | 0.3% |
ANLN | AD | 1 (0.8%) | 0.3% |
TRPC6 | AD | 1 (0.8%) | 0.3% |
TP53RK | AR | 1 (0.8%) | 0.3% |
PODXL | AR | 1 (0.8%) | 0.3% |
DGKE | AR | 1 (0.8%) | 0.3% |
FOXP3 | X-linked | 1 (0.8%) | 0.3% |
LCAT COQ2 | AR AR | 1 (0.8%) 1 (0.8%) | 0.3% 0.3% |
Subtotal | 113 (89.0%) | 38.8% | |
Phenocopying gene | |||
COL4A5 | X-linked | 6 (4.7%) | 2.1% |
COL4A4 | AD/AR | 4 (3.1%) | 1.4% |
WDR19 | AR | 3 (2.4%) | 1.0% |
COL4A3 | AD | 1 (0.8%) | 0.3% |
Subtotal | 14 (11.0%) | 4.8% | |
Total | 127 (100%) | 43.6% |
Trautmann et al., 2015 [3] | Sadowski et al., 2015 [4] | Bierzynska et al., 2017 [2] | Wang et al., 2017 [5] | Warejko et al., 2018 [23] | Nagano et al., 2020 [6] | This Study | |
---|---|---|---|---|---|---|---|
Country | International | International | United Kingdom | China | International | Japan | Korea |
Modality | GP (31 genes) | GP (27 genes) | WES (53 genes) | GP (28 genes) | WES | GP (60 genes) | Sanger/GP (57 genes) c |
Detection rate a | 277/1174 (23.6%) | 526/1783 (29.5%) | 49/187 (26.2%) | 34/120 (28.3%) | 85/300 (28.3%) | 69/230 (30.0%) | 127/291 (43.6%) |
Commonly mutated genes b | NPHS2 138 (49.8%) | NPHS2 177 (33.7%) | NPHS1 14 (28.6%) | COQ8B 8 (23.5%) | NPHS1 13 (15.3%) | WT1 17 (24.6%) | WT1 30 (23.6%) |
WT1 48 (17.3%) | NPHS1 131 (24.9%) | NPHS2 12 (24.5%) | NPHS1 7 (20.6%) | PLCE1 11 (12.9%) | NPHS1 8 (11.6%) | COQ6 11 (8.7%) | |
NPHS1 41 (14.8%) | WT1 85 (16.2%) | WT1 4 (8.2%) | WT1 7 (20.6%) | NPHS2 8 (9.4%) | INF2 8 (11.6%) | NPHS1 11 (8.7%) | |
SMARCAL1 12 (4.3%) | PLCE1 37 (7.0%) | NUP107 4 (8.2%) | NPHS2 4 (11.8%) | SMARCAL1 8 (9.4%) | TRPC6 7 (10.1%) | NUP107 9 (7.1%) | |
PLCE1 10 (3.6%) | LAMB2 20 (3.8%) | TRPC6 3 (6.1%) | LMX1B 2 (5.9%) | LAMB2 6 (7.1%) | LAMB2 6 (8.7%) | COQ8B 8 (6.3%) |
Gene | Patient ID | Mutations | Age at Onset (Years) | Sex b | Family History | Mode of Onset | Kidney Biopsy | Renal Outcome | Time to ESRD (Years) |
---|---|---|---|---|---|---|---|---|---|
WT1 (REFSEQ: NM_024426.5) | |||||||||
SRNS-20 | c.1400G > A, p.R467Q | At birth | M | N | NS | ND | ESRD | 0.1 | |
SRNS-42 | c.1136delT, p.V379Dfs a | 6.5 | M | N | PU | FSGS | ESRD | 2.7 | |
SRNS-126 | c.1231C > T, p.H411Y a | 1.5 | F | N | NS | FSGS | ESRD | 7.3 | |
SRNS-151 | c.1315C > T, p.R439C | At birth | M | N | NS | ND | ESRD | 0.0 | |
SRNS-156 | c.760C > A, p.P254T a | 3.3 | M | N | NS | FSGS | ESRD | 6.1 | |
SRNS-186 | c.1363C > T, p.P455S | 8.0 | M | Y | NS | FSGS | Normal eGFR | NA | |
SRNS-222 | c.1316G > A, p.R439H | At birth | M | N | NS | FSGS | ESRD | 0.4 | |
SRNS-223 | c.1316G > A, p.R439H | At birth | F | N | NS | DMS | ESRD | 0.0 | |
SRNS-224 | c.1316G > A, p.R439H | At birth | F | N | NS | FSGS | Death | NA | |
SRNS-225 | c.1316G > A, p.R439H | At birth | F | N | NS | ND | ESRD | 0.0 | |
SRNS-226 | c.1316G > C, p.R439P | At birth | M | NA | PU | ND | ESRD | 1.8 | |
SRNS-227 | c.1315C > T, p.R439C | At birth | F | N | NS | ND | ESRD | 0.0 | |
SRNS-228 | c.1324C > A, p.Q442K | 1.0 | F | N | ESRD | ND | ESRD | 0.0 | |
SRNS-229 | c.1372T > A, p.C458S | At birth | M | N | NS | DMS | ESRD | 1.1 | |
SRNS-230 | c.1399C > T, p.R467W | At birth | M | N | PU | DMS | ESRD | 1.8 | |
SRNS-231 | c.1405G > T, p.D469Y | At birth | F | NA | NS | DMS | ESRD | 0.0 | |
SRNS-232 | c.785 − 1G > C in intron 2 a | NA | M | NA | NA | ND | NA | NA | |
SRNS-233 | c.1447 + 4C > T in intron 9 | 6.6 | F | N | NS | FSGS | CKD | NA | |
SRNS-234 | c.1447 + 4C > T in intron 9 | 2.6 | F | N | NS | FSGS | Normal eGFR | NA | |
SRNS-235 | c.1447 + 4C > T in intron 9 | 3.5 | M | N | ESRD | ND | ESRD | 0.0 | |
SRNS-236 | c.1447 + 4C > T in intron 9 | 6.8 | M | N | NS | MesPGN | ESRD | 15.4 | |
SRNS-237 | c.1447 + 4C > T in intron 9 | At birth | F | N | CKD | ND | ESRD | 0.7 | |
SRNS-238 | c.1447 + 5G > A in intron 9 | At birth | M | N | PU | FSGS | ESRD | 19.7 | |
SRNS-239 | c.1447 + 5G > A in intron 9 | 5.0 | F | N | NS | FSGS | ESRD | 4.2 | |
SRNS-240 | c.1447 + 5G > A in intron 9 | 6.8 | F | N | PU | FSGS | ESRD | 12.9 | |
SRNS-241 | c.1447 + 5G > A in intron 9 | 11.4 | M | N | CKD | FSGS | ESRD | 0.3 | |
SRNS-242 | c.1447 + 5G > A in intron 9 | 12.3 | M | N | PU | FSGS | Normal eGFR | NA | |
SRNS-243 | c.1419_1430del12, p.H474_T477del a | At birth | M | N | ESRD | ND | ESRD | 0.0 | |
SRNS-244 | c.1381T > C, p.C461R | 2.2 | F | N | ESRD | MesPGN | ESRD | 0.0 | |
SRNS-245 | c.1297T > C, p.C433R | At birth | F | N | ESRD | ND | ESRD | 0.0 | |
COQ6 (REFSEQ: NM_182476.2) | |||||||||
SRNS-61 | c.686A > C, p.Q229P c.782C > T, p.P261L | 1.1 | M | N | PU | FSGS | Normal eGFR | NA | |
SRNS-103 | c.124G > T, p.G42C a c. 782C > T, p.P261L | At birth | F | N | NS | FSGS | ESRD | 0.4 | |
SRNS-203 | c.484C > T, p.R162* c.782C > T, p.P261L | 9.1 | M | N | PU | FSGS | ESRD | 0.8 | |
SRNS-251 | c.189_191del3, p.K64del c.782C > T, p.P261L | 3.9 | M | N | NS | FSGS | ESRD | 2.2 | |
SRNS-252 | c.189_191del3, p.K64del c.686A > C, p.Q229P | 2.0 | F | N | NS | FSGS | ESRD | 1.1 | |
SRNS-253 | c.189_191del3, p.K64del c.782C > T, p.P261L | 3.9 | F | N | NS | FSGS | ESRD | 0.1 | |
SRNS-254 | c.189_191del3, p.K64del c.782C > T, p.P261L | 2.7 | F | N | NS | FSGS | ESRD | 1.9 | |
SRNS-255 | c.189_191del3, p.K64del c.782C > T, p.P261L | 1.2 | F | Y | NS | FSGS | ESRD | 0.1 | |
SRNS-256 | c.189_191del3, p.K64del c.782C > T, p.P261L | 3.1 | M | N | NS | FSGS | ESRD | 0.4 | |
SRNS-257 | c.686A > C, p.Q229P c.782C > T, p.P261L | At birth | M | N | NS | FSGS | ESRD | 1.7 | |
SRNS-258 | c.189_191del3, p.K64del c.782C > T, p.P261L | 1.1 | M | N | NS | FSGS | ESRD | 0.2 | |
NPHS1 (REFSEQ: NM_004646.3) | |||||||||
SRNS-85 | c.2156_2163del8, p.L719Pfs*4 c.2464G > A, p.V822M | At birth | F | Y | NS | MesPGN | Death | 0.0 | |
SRNS-206 | c.2156_2163del8, p.L719Pfs*4 c.3250dupG, p.V1084Gfs*12 | At birth | M | N | NS | MesPGN | ESRD | 2.5 | |
SRNS-207 | c.2442C > G, p.Y814* c.1379G > A, p.R460Q | At birth | F | N | NS | ND | ESRD | 3.0 | |
SRNS-208 | c.188A > G, p.Q63R c.1885G > T, p.E629* | At birth | M | N | NS | FSGS | ESRD | 1.6 | |
SRNS-209 | c.3027C > G, p.Y1009* c.3478C > T, p.R1160* | At birth | F | N | NS | ND | ESRD | 3.2 | |
SRNS-210 | c.2765C > A, p.A922D c.3287 − 11G > A in intron 24 | At birth | M | N | NS | FSGS | CKD | NA | |
SRNS-211 | c.2156_2163del8, p.L719Pfs*4 c.3478C > T, p.R1160* | At birth | M | N | NS | ND | ESRD | 4.7 | |
SRNS-212 | c.58 + 2T > C in intron 1 a c.1338delT, p.I466Mfs*16 a | At birth | F | Y | NS | MesPGN | ESRD | 1.5 | |
SRNS-213 | c.526 + 1G > A in intron 4 c.1632_1634del3, p.545del | At birth | M | N | NS | ND | Normal eGFR | NA | |
SRNS-214 | c.3213dupG, p.L1072Afs*24 a c.3478C > T, p.R1160* | At birth | M | N | NS | ND | Death | 0.0 | |
SRNS-215 | c.139delG, p.A47Pfs*81 (homozygote) | At birth | M | N | NS | MesPGN | ESRD | 1.8 | |
NUP107 (REFSEQ: NM_020401.3) | |||||||||
SRNS-71 | c.934delT, p.Y312Tfs a c.2492A > C, p.D831A | 4.8 | M | N | PU | FSGS | ESRD | 8.7 | |
SRNS-259 | c.2071C > T, p.Q691* c.2492A > C, p.D831A | 4.3 | M | Y | NS | FSGS | ESRD | 4.2 | |
SRNS-260 | c.627_663dup37, p.L225Ffs*15 a c.2492A > C, p.D831A | 3.8 | F | N | PU | FSGS | ESRD | 3.0 | |
SRNS-261 | c.1079_1083del5, p.E360Gfs*6 c.2492A > C, p.D831A | 3.4 | M | Y | NS | FSGS | ESRD | 2.0 | |
SRNS-262 | c.1079_1083de5l, p.E360Gfs*6 c.2492A > C, p.D831A | 2.4 | M | N | PU | FSGS | ESRD | 2.7 | |
SRNS-263 | c.1079_1083del5, p.E360Gfs*6 c.2492A > C, p.D831A | 3.8 | M | N | ESRD | ND | ESRD | 0.0 | |
SRNS-264 | c.469G > T, p.D157Y c.2492A > C, p.D831A | 10.9 | F | Y | CKD | FSGS | ESRD | 2.1 | |
SRNS-265 | c.1079_1083del5, p.E360Gfs*6 c.2492A > C, p.D831A | 4.0 | F | N | ESRD | ND | ESRD | 0.0 | |
SRNS-266 | c.2492A > C, p.D831A c.1735 − 3T > G in intron 20 | 4.1 | M | Y | PU | FSGS | ESRD | 7.4 | |
COQ8B (REFSEQ: NM_024876.3) | |||||||||
SRNS-25 | c.759C > A, p.N253K (homozygote) | 1.1 | F | NA | NS | FSGS | ESRD | 1.5 | |
SRNS-35 | c.737G > A, p.S246N c.532C > T, p.R178W | 6.7 | M | N | PU | FSGS | CKD | NA | |
SRNS-93 | c.737G > A, p.S246N c.1548C > A, p.Y516* a | 9.9 | F | N | PU | FSGS | Normal eGFR | NA | |
SRNS-246 | c.449G > A, p.R150Q c.759C > A, p.N253K | 5.1 | M | Y | PU | FSGS | ESRD | 5.1 | |
SRNS-247 | c.737G > A, p.S246N c.759C > A, p.N253K | 10.8 | F | N | PU | FSGS | ESRD | 2.0 | |
SRNS-248 | c.737G > A, p.S246N (homozygote) | 9.2 | F | N | PU | FSGS | ESRD | 3.0 | |
SRNS-249 | c.737G > A, p.S246N c.1468C > T, p.R490C | 6.9 | F | N | PU | FSGS | ESRD | 3.9 | |
SRNS-250 | c.737G > A, p.S246N (homozygote) | 13.0 | F | N | PU | FSGS | Normal eGFR | NA | |
MYH9 (REFSEQ: NM_002473.5) | |||||||||
SRNS-205 | c.3494G > T, p.R1165L | 16.8 | F | Y | PU | ND | ESRD | 17.5 | |
SRNS-273 | c. 2152C > T, p.R718W | 1.3 | M | N | NS | MesPGN | ESRD | 5.3 | |
SRNS-274 | c.287C > T, p.S96L | 20.0 | M | N | PU | FSGS | ESRD | 0.7 | |
SRNS-275 | c.287C > T, p.S96L | 12.1 | F | N | PU | ND | ESRD | 8.3 | |
SRNS-276 | c.2104C > T, p.R702C | 8.7 | F | NA | PU | MesPGN | ESRD | 7.8 | |
SRNS-277 | c.287C > T, p.S96L | 12.4 | M | NA | PU | MesPGN | ESRD | 10.5 | |
INF2 (REFSEQ: NM_022489.3) | |||||||||
SRNS-63 | c.233T > G, p.L78R a | 11.0 | M | N | PU | FSGS | ESRD | 6.7 | |
SRNS-69 | c.658G > A, p.E220K | 11.1 | F | N | PU | FSGS | ESRD | 4.0 | |
SRNS-268 | c.658G > A, p.E220K | 7.4 | M | Y | PU | FSGS | ESRD | 5.8 | |
SRNS-269 | c.658G > A, p.E220K | 11.7 | M | N | NS | FSGS | ESRD | 5.5 | |
SRNS-270 | c.230T > C, p.L77P | 9.2 | F | N | NS | FSGS | ESRD | 3.4 | |
SRNS-271 | c.529C > T, p.R177C | 12.6 | F | Y | PU | FSGS | Normal eGFR | NA | |
PAX2 (REFSEQ: NM_003987.4) | |||||||||
SRNS-26 | c.76dupG, p.V26Gfs*28 | 5.3 | M | N | PU | FSGS | ESRD | 10.2 | |
SRNS-31 | c.563A > G, p.N188S a | 3.4 | M | N | NS | ND | Normal eGFR | NA | |
SRNS-32 | c.222_225dup4, p.G76Dfs a | 13.4 | M | Y | PU | FSGS | CKD | NA | |
SRNS-95 | c.74G > A, p.G25E a | 7.2 | F | N | PU | FSGS | ESRD | 7.3 | |
SRNS-191 | c.419G > A, p.R140Q | 7.8 | M | N | PU | FSGS | Normal eGFR | NA | |
NPHS2 (REFSEQ: NM_014625.3) | |||||||||
SRNS-27 | c.503G > A, p.R168H c.467dupT, p.L156Ffs*11 | 1.3 | F | NA | NS | ND | ESRD | 3.6 | |
SRNS-47 | c.412C > T, p.R138* c.503G > A, p.R168H | 2.1 | M | N | NS | FSGS | ESRD | 4.9 | |
SRNS-136 | c.502C > T, p.R168C c.851C > T, p.A284V | 6.9 | M | N | PU | FSGS | CKD | NA | |
SRNS-216 | c.358T > C, p.S120P c.503G > A, p.R168H | At birth | M | N | NS | FSGS | ESRD | 8.4 | |
COL4A5 (REFSEQ: NM_000495.4) | |||||||||
SRNS-49 | c.834 + 1G > A in intron 14 | 10.0 | F | Y | PU | FSGS | CKD | NA | |
SRNS-81 | c.956G > A, p.G319D | 10.1 | M | Y | PU | FSGS | ESRD | 10.1 | |
SRNS-87 | c.4946delT, p.L1649Rfs*4 a | 12.9 | M | Y | PU | FSGS | ESRD | 6.7 | |
SRNS-120 | c.1165 + 1G > A in intron 19 | 3.8 | M | N | NS | FSGS | ESRD | 6.7 | |
SRNS-134 | c.4082T > A, p.L1361* a | 14.0 | M | Y | PU | FSGS | ESRD | 8.4 | |
SRNs-190 | c.4532G > A, p.R1511H | 12.8 | M | N | PU | FSGS | CKD | NA | |
COL4A4 (REFSEQ: NM_000092.4) | |||||||||
SRNS-53 | c.1111delG, p.D371Tfs a c.1323_1340del18, p.P444_L449del | 0.8 | F | Y | PU | MesPGN | ESRD | 18.9 | |
SRNS-148 | c.2630G > A, p.R877Q | 3.6 | M | N | NS | ND | Death | 2.3 | |
SRNS-152 | c.1046G > A, p.R349Q a | 2.5 | F | N | NS | FSGS | Normal eGFR | NA | |
SRNS-181 | c.2630G > A, p.R877Q | 14.3 | F | N | PU | FSGS | Normal eGFR | NA | |
MAFB (REFSEQ: NM_005461.4) | |||||||||
SRNS-204 | c.194G > T, p.S65I | 9.8 | M | Y | PU | ND | Normal eGFR | NA | |
SRNS-280 | c.183C > A, p.S61R | 12.5 | F | N | PU | FSGS | CKD | NA | |
SRNS-281 | c.211C > G, p.P71A | 4.4 | M | N | PU | FSGS | ESRD | 0.6 | |
SRNS-282 | c.212C > T, p.P71L | 1.2 | M | N | PU | ND | Normal eGFR | NA | |
LAMB2 (REFSEQ: NM_002292.3) | |||||||||
SRNS-217 | c.1503_1504delAT, p.C502* c.4267delT, p.C1423Vfs*29 | 0.7 | F | N | NS | FSGS | ESRD | 10.8 | |
SRNS-218 | c.2283-2286del4, p.S762Rfs*29 c.536C > T, p.S179F | At birth | F | N | NS | FSGS | CKD | NA | |
SRNS-219 | c.474delT, p.A159Pfs*33 a c.1328_1329del2, p.H443Rfs*11 a | At birth | F | N | NS | ND | ESRD | 0.1 | |
WDR19 (REFSEQ: NM_025132.3) | |||||||||
SRNS-289 | c.3533G > A, p.R1178Q c.3703G > A, p.E1235K | 9.6 | M | N | PU | FSGS | ESRD | 1.4 | |
SRNS-290 | c.3533G > A, p.R1178Q c.3703G > A, p.E1235K | 6.2 | F | Y | PU | MesPGN | ESRD | 3.0 | |
SRNS-291 | c.1853T > C, p.L618P c.3533G > A, p.R1178Q | At birth | M | N | CKD | ND | ESRD | 0.3 | |
SMARCAL1 (REFSEQ: NM_014140.3) | |||||||||
SRNS-144 | c.1682G > A, p.R561H c.1851 + 1G > T in intron 9 a | 6.0 | M | N | NS | FSGS | ESRD | 3.4 | |
SRNS-287 | c.1411dupA, p.I471Nfs a c.1484A > C, p.Q495P a | 5.5 | F | N | NS | FSGS | ESRD | 1.5 | |
SRNS-288 | c.1484A > C, p.Q495P a c.1851 + 1G > T in intron 9 a | 3.5 | M | N | PU | FSGS | ESRD | 2.1 | |
MT-TL1 (REFSEQ: NC_012920) | |||||||||
SRNS-284 | mtDNA3243A > G | 18.9 | F | Y | PU | DMS | CKD | NA | |
SRNS-285 | mtDNA3243A > G | 11.8 | F | Y | PU | FSGS | ESRD | 6.0 | |
SRNS-286 | mtDNA3243A > G | 9.8 | F | N | PU | FSGS | ESRD | 5.3 | |
FOXP3 (REFSEQ: NM_014009.3) | |||||||||
SRNS-283 | c.736 − 2A > G in intron 7 a | 3.4 | M | N | NS | MNP | Normal eGFR | NA | |
ACTN4 (REFSEQ: NM_004924.5) | |||||||||
SRNS-267 | c.785C > T, p.S262F | 3.5 | M | Y | NS | FSGS | ESRD | 1.2 | |
LMX1B (REFSEQ: NM_002316.3) | |||||||||
SRNS-279 | c. 668G > A, p.R223Q | 2.1 | F | N | NS | FSGS | ESRD | 1.86 | |
ANLN (REFSEQ: NM_018685.4) | |||||||||
SRNS-65 | c.2305A > T, p.L769* a | 7.7 | M | N | PU | FSGS | Normal eGFR | NA | |
TRPC6 (REFSEQ: NM_004621.5) | |||||||||
SRNS-37 | c.523C > G, p.R175G a | 8.5 | F | N | PU | FSGS | ESRD | 2.3 | |
COL4A3 (REFSEQ: NM_000091.4) | |||||||||
SRNS-199 | c.4793T > G, p.L1598R | 0.5 | F | N | NS | DMS | ESRD | 0.9 | |
TP53RK (REFSEQ: NM_033550.3) | |||||||||
SRNS-221 | c.194A > T, p.K65M (homozygote) | At birth | F | NA | NA | ND | Death | 0.0 | |
DGKE (REFSEQ: NM_003647.2) | |||||||||
SRNS-272 | c.501C > G, p.C167W c.610dupA, p.T204Nfs*4 | 0.5 | M | N | PU | FSGS | CKD | NA | |
LCAT (REFSEQ: NM_000229.1) | |||||||||
SRNS-278 | c.794_801del8, p.E265Afs*18 c.931delT, p.F311Lfs*99 a | 9.6 | M | Y | PU | FSGS | Normal eGFR | NA | |
COQ2 (REFSEQ: NM_015697.7) | |||||||||
SRNS-168 | c.392A > G, p.D131G a c.518G > A, p.R173H a | At birth | F | N | NS | FSGS | ESRD | 0.3 | |
PODXL (REFSEQ: NM_005397.3) | |||||||||
SRNS-220 | c.3G > T, p.M1? c.926G > A, p.W309* | At birth | M | Y | NS | ND | ESRD | 0.0 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Park, E.; Lee, C.; Kim, N.K.D.; Ahn, Y.H.; Park, Y.S.; Lee, J.H.; Kim, S.H.; Cho, M.H.; Cho, H.; Yoo, K.H.; et al. Correction: Park et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013. J. Clin. Med. 2022, 11, 3016. https://doi.org/10.3390/jcm11113016
Park E, Lee C, Kim NKD, Ahn YH, Park YS, Lee JH, Kim SH, Cho MH, Cho H, Yoo KH, et al. Correction: Park et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013. Journal of Clinical Medicine. 2022; 11(11):3016. https://doi.org/10.3390/jcm11113016
Chicago/Turabian StylePark, Eujin, Chung Lee, Nayoung K. D. Kim, Yo Han Ahn, Young Seo Park, Joo Hoon Lee, Seong Heon Kim, Min Hyun Cho, Heeyeon Cho, Kee Hwan Yoo, and et al. 2022. "Correction: Park et al. Genetic Study in Korean Pediatric Patients with Steroid-Resistant Nephrotic Syndrome or Focal Segmental Glomerulosclerosis. J. Clin. Med. 2020, 9, 2013" Journal of Clinical Medicine 11, no. 11: 3016. https://doi.org/10.3390/jcm11113016